USPTO serial 77076522
MR. GENE
Reviewed by CopyMark Law Group
Reg. 3338270Status 710
- Filing date
- Status date
- Registration date
- Nov 20, 2007
- Examiner
- CHISOLM, KEVON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with MR. GENE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Regensburg, DE
Regensburg, DE
Regensburg, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Phil Makrogiannis
Phil Makrogiannis Life Technologies Corporation5791 Van Allen WayCarlsbad, CA 92008UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for laboratory analysis in the field of biotechnology, drug discovery, genomics, molecular biology and microbiology; chemical preparations for scientific purposes in the field of biotechnology, drug discovery, genomics, molecular biology and microbiology; bacteria preparations for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; bacteriological preparations for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; micro-organism cultures for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; biochemical catalysts for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; biological materials for clinical, scientific, research and medical laboratories, namely, proteins, DNA, RNA and modifications thereof; diagnostic materials for clinical, scientific, research and medical purposes, namely, proteins, DNA, RNA and modifications thereof; enzymes and enzyme preparations for use in the field of food manufacture, waste treatment, fermentation, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds | SECTION 8 - CANCELLED | — |
| 005 | Medicines for human-medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; medicines for dental purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, Alzheimer's and infectious diseases; medicines for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; bacteriological preparations for medical and veterinary purposes for use in the treatment of cancer, high blood pressure, diarrhea, skin irritations, infections, diabetes, autoimmune diseases and arthritis as well as for use in gene therapy; biological preparations for medical purposes namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; biological preparations for veterinary purposes namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; germicides for medical and laboratory equipment, institutional, domestic uses; vermicides for medical and laboratory equipment, institutional, domestic, residential uses; fungicides for medical and laboratory equipment, institutional, domestic uses; biological materials for medical diagnostic laboratories, namely, proteins, DNA, RNA and modifications thereof; diagnostic materials for clinical and medical laboratory purposes, namely, proteins, DNA, RNA and modifications thereof; deoxyribonucleic acid, especially deoxyribonucleic acid comprising 80 to 150 base pairs; and genes, especially genes comprising 80 to 150 base pairs | SECTION 8 - CANCELLED | — |
| 007 | Automatic machines for the synthesis of deoxyribonucleinic acid; machine housings; pump membranes; regulators being part of machines; pressure regulators being part of machines; and industrial robots | SECTION 8 - CANCELLED | — |
| 009 | Scientific and laboratory equipment, namely, automatic machines for the synthesis of deoxyribonucleinic acids; robot machines for laboratory purposes; computer terminals; computer programs for use as tools in the field of biotechnology and molecular biology; computer software to increase potency of enzymes and enzyme preparations, bacteria preparations, bacteriological preparations, micro-organism cultures, biological preparations, diagnostic preparations; computer operating programs; computer keyboards; blank magnetic data carriers; blank optical disks; computer memories; blank floppy disks; hard drives for computers; printers for use with computers; computer interfaces; laptop computers; data processors, namely, readers and scanners; computer mouse; semiconductors; computer modems; computer monitors; computer hardware; and notebook computers | SECTION 8 - CANCELLED | — |
| 042 | Computer services, namely, updating of computer software for others, consulting in the field of biotechnology; designing computer software for others, maintenance of computer software for others, leasing of computer software, computer programming for others, leasing of computers and reconstruction of computer data for others; chemical analysis for others; research for others in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, and machine engineering; laboratory services, namely, DNA engineering and processing for others in the fields of bacteriology and chemistry; consultation in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering and machine engineering; measuring calibration for others; development and research of new products for others; technical consultation in the field of environmental protection; technical project planning and consulting services in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, and machine engineering; and quality control for others | SECTION 8 - CANCELLED | — |
| 044 | Providing a computer database in the fields of medicines, pharmaceuticals, and genomics; consultation in the field of pharmacy | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Geneart AG
- Other trademarks owned by Geneart AG
- Other trademarks owned by Geneart AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MR. GENE
- Prosecution event ARAA explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 23, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 27, 2014 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 21, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 21, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 2, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 2, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 1, 2011 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 20, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 20, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 4, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 29, 2007 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Aug 15, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 31, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 31, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 25, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 25, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 23, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 24, 2007 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 24, 2007 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 24, 2007 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 13, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 13, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 13, 2007 | ALIE | ASSIGNED TO LIE | — |
| May 29, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 1, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 25, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 9, 2007 | NWAP | NEW APPLICATION ENTERED | — |